Literature DB >> 20182847

Experimental verification of age-dependent cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced computed tomography.

Atsushi Tachibana1, Ayumu Nagasawa, Akihiro Kitamura, Shohei Miyazaki, Kenya Murase.   

Abstract

PURPOSE: The aim of this study was to investigate age-dependent cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced computed tomography (DCE-CT).
MATERIALS AND METHODS: The DCE-CT studies were performed in 23 rats aged 4 weeks (n = 6), 6 weeks (n = 6), 8 weeks (n = 6), and 24 weeks (n = 5) on days 0, 2, 4, and 7. The rats were given intraperitoneally cisplatin 3.6 mg/kg body weight (BW) on day 0. The contrast clearance per unit renal volume (K (1)) was estimated using the Patlak model, and that of the entire kidney (K) was obtained by multiplying K(1) by the renal volume (V).
RESULTS: On day 0, the K(1) value increased up to 8 weeks and dropped thereafter. The V and K values increased with age. The K value per unit BW was maximum at 4 weeks, remained relatively unchanged between 6 and 8 weeks, and dropped thereafter. The BW, K(1), and K values normalized by those on day 0 became lower in old rats than in young ones, and the differences among rats of different ages became greater with days after cisplatin injection, indicating that the cisplatin-induced nephrotoxicity becomes more severe with age.
CONCLUSION: This study demonstrated the existence of age-dependent difference in cisplatin-induced nephrotoxicity in rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182847     DOI: 10.1007/s11604-009-0396-2

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  18 in total

1.  Determination of the glomerular filtration rate (GFR): methodological problems, age-dependence, consequences of various surgical interventions, and the influence of different drugs and toxic substances.

Authors:  C Fleck
Journal:  Physiol Res       Date:  1999       Impact factor: 1.881

2.  Dynamic CT measurement of cerebral blood flow: a validation study.

Authors:  A Cenic; D G Nabavi; R A Craen; A W Gelb; T Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

3.  Effects of age on levels of cysteine, glutathione and related enzyme activities in livers of mice and rats and an attempt to replenish hepatic glutathione level of mouse with cysteine derivatives.

Authors:  K Nakata; M Kawase; S Ogino; C Kinoshita; H Murata; T Sakaue; K Ogata; S Ohmori
Journal:  Mech Ageing Dev       Date:  1996-09-30       Impact factor: 5.432

4.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

5.  Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.

Authors:  R F Borch; M E Pleasants
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

6.  A method for quantitative assessment of renal function using dynamic contrast-enhanced computed tomography: evaluation of drug-induced nephrotoxicity in rats.

Authors:  Kenya Murase; Atsushi Tachibana; Yoshinori Kusakabe; Risa Matsuura; Shohei Miyazaki
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

7.  Lack of age-dependent cisplatin nephrotoxicity.

Authors:  W J Hrushesky; W Shimp; B J Kennedy
Journal:  Am J Med       Date:  1984-04       Impact factor: 4.965

8.  Ontogenic aspects of cisplatin-induced nephrotoxicity in rats.

Authors:  B H Ali; M Al-Moundhri; M Tageldin; I S Al Husseini; Mohmed A Mansour; A Nemmar; M O Tanira
Journal:  Food Chem Toxicol       Date:  2008-08-26       Impact factor: 6.023

9.  Nephrotoxicity of cis-platin comparing young and adult rats.

Authors:  H T Jongejan; A P Provoost; E D Wolff; J C Molenaar
Journal:  Pediatr Res       Date:  1986-01       Impact factor: 3.756

10.  Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions.

Authors:  F Oshita; T Kurata; T Kasai; M Fakuda; N Yamamoto; Y Ohe; T Tamura; K Eguchi; T Shinkai; N Saijo
Journal:  Jpn J Cancer Res       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.